Search clinical trials for: EBI-005-1

Total 19432 results

Aadi Bioscience, Inc.

Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Cancer | Endometrial Cancer | Tumor | Recurrent Endometrial Carcinoma | Endometrioid Endometrial Cancer | Endometrioid Tumor

United States
Portuguese Oncology Institute, Coimbra

Completed

Follow-up Protocol of Colorectal Endoscopic Mucosal Resection Scars

Colorectal Cancer | Recurrence, Local Neoplasm

Portugal
Cryonove Pharma
CEISO; Dermatech; Sefako Makgatho Health Sciences University

Completed

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots.

Solar Lentigo | Post-inflammatory Hyperpigmentation | Senile Lentigo

South Africa
Click Therapeutics, Inc.

Recruiting

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Multiple Sclerosis | Breast Cancer | Lung Cancer

United States
MediciNova

Recruiting

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Diabetes Mellitus, Type 2 | Hypertriglyceridemia | Non-Alcoholic Fatty Liver Disease

United States
Ocellaris Pharma, Inc.

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Sarcoma | Neoplasms | Renal Cell Carcinoma | Cervical Cancer | Cancer | Hepatocellular Carcinoma | Gastric Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Squamous... and other conditions

Canada
Castle Creek Biosciences, LLC.

Active, not recruiting

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (DEFI-RDEB)

Recessive Dystrophic Epidermolysis Bullosa

United States
BiondVax Pharmaceuticals ltd.

Completed

Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV (BVX006)

Influenza

Israel
University of Maryland, Baltimore
University of Maryland Medical System

Withdrawn

UM CRMC RecuR Score Pilot

Heart Failure | Pneumonia | Hypertension | Pulmonary Disease, Chronic Obstructive | Patient Readmission | Diabetes Mellitus Poor Control

United States
Ocera Therapeutics, Inc.

No longer available

Emergency Use of OCR-002 in Acute Liver Failure (ALF)

Acute Liver Failure

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC (NPC)

Head and Neck Cancer

United States
Hospital Hietzing

Completed

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

Diabetic Retinal Edema

Austria
GPCR Therapeutics, Inc.

Completed

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Multiple Myeloma | Hodgkin Disease | Non-Hodgkin Lymphoma

Taiwan
Drugs for Neglected Diseases
Bayer

Active, not recruiting

Emodepside Phase II Trial for Treatment of Onchocerciasis

Onchocerciasis

Ghana, Congo, The Democratic Republic of the
Yanqiao Zhang

Unknown

Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients

Gastric Adenocarcinoma
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

Pancreatic Adenocarcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7

United States
VA Office of Research and Development
Veterans Health Administration Office of Primary Care; Veterans Health Administration... and other collaborators

Recruiting

High-Risk Veteran Initiative (RIVET)

Multimorbidity

United States
Heidelberg University

Completed

Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous Emphysema

Pulmonary Emphysema

Germany
Shanghai Jiao Tong University School of Medicine

Completed

Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB

Early Gastric Cancer

China
Celgene Corporation

Withdrawn

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

Metastatic Melanoma
University of Surrey
The Whiteley Clinic

Completed

Investigation Into the Pathophysiology and Treatment of Varicose Veins

Varicose Veins

United Kingdom
BiondVax Pharmaceuticals ltd.

Completed

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers

Influenza

Israel
Stoke Therapeutics, Inc

Completed

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

Dravet Syndrome

United States
First Affiliated Hospital of Fujian Medical University

Withdrawn

Fingolimod in COVID-19

Coronavirus Disease (COVID-19)

China
Novartis Pharmaceuticals

Completed

Fingolimod Effect on Cytokine and Chemokine Levels

Relapsing Remitting Multiple Sclerosis

Turkey
Novartis Pharmaceuticals

Terminated

Effect of Fingolimod on Neurodegeneration

Cognition | Brain Volume Loss

Turkey
Danone Research

Completed

Effect of the Consumption of a Fermented Milk on Common Infections in Children Aged 3-6 Years, Attending Day Care Centers

Common Infectious Diseases

Russian Federation
Pardes Biosciences, Inc.

Completed

Study of PBI-0451 in Healthy Subjects.

Covid19

New Zealand
Emory University

Completed

Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)

Breast Cancer

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Zaleplon Single Dose Pharmacokinetics

Healthy

United States
Ascentawits Pharmaceuticals, Ltd

Recruiting

A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors

Pancreatic Cancer | Solid Tumor

China
Wave Life Sciences Ltd.

Recruiting

A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1) (RestorAATion-1)

Alpha-1 Antitrypsin Deficiency

United Kingdom
Shijiazhuang Yiling Pharmaceutical Co. Ltd

Recruiting

A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours

Solid Tumor, Adult

China
Frontera Therapeutics
Peking Union Medical College Hospital; The First Affiliated Hospital of Zhengzhou... and other collaborators

Recruiting

Gene Therapy for Diabetic Macular Edema

Diabetic Macular Edema

China
Frontera Therapeutics
Peking Union Medical College Hospital; Eye & ENT Hospital of Fudan University; Henan Provincial People's Hospital

Recruiting

Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa

X-Linked Retinitis Pigmentosa

China
Beckley Psytech Limited

Recruiting

BPL-003 Efficacy and Safety in Treatment Resistant Depression

Treatment Resistant Depression

Spain, Germany, United States, Poland, Australia, United Kingdom
Innovo Therapeutics, Inc.

Recruiting

Ointment to Prevent Scar After Thyroidectomy

Scar

Korea, Republic of
Amgen

Recruiting

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Spain, Australia, Germany, France, Japan
Lin BioScience, Inc
Lin BioScience Pty Ltd

Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

Relapsed or Resistant Acute Leukaemias

Taiwan, Australia
Beckley Psytech Limited

Recruiting

An Open-Label, Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

Treatment Resistant Depression

United Kingdom
Frontera Therapeutics
Peking Union Medical College Hospital; The First Affiliated Hospital of Soochow... and other collaborators

Not yet recruiting

Gene Therapy for Wet AMD

Neovascular Age-related Macular Degeneration
jianming xu
KAEDI

Recruiting

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Solid Tumor | CRC

China
ImmuneOncia Therapeutics Inc.

Recruiting

A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy

Advanced Cancer

Korea, Republic of
Da Zen Theranostics Inc

Recruiting

A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma

Lymphoma | Solid Tumor

United States
Everfront Biotech Co., Ltd.

Not yet recruiting

A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer

Pancreatic Cancer
MedRhythms, Inc.

Active, not recruiting

Facilitators and Barriers to the Clinical Implementation of MR-001 (RhaPSody)

Chronic Stroke

United States
Avalo Therapeutics, Inc.

Completed

Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Stoke Therapeutics, Inc

Enrolling by invitation

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

Dravet Syndrome

United States
Dr. Noah Biotech Inc.

Completed

Multiple Dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability of NDC-002 in Healthy Volunteers

Stroke | Stroke Sequelae

Korea, Republic of
Wave Life Sciences Ltd.

Terminated

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

ALS | FTD

Netherlands, United Kingdom

Search clinical trials for: EBI-005-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations